ArticleFrontiers in immunology2025

Case Report: Efgartigimod as an additional therapy for MOG antibody-associated disease overlapping GFAP-IgG.

Yun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.